| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.4 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |